Nov 28 (Reuters) - Exopharm Ltd (EX1) :
- IAN DIXON EMPLOYMENT AS CEO IS EXPECTED TO END IN EARLY CY 24.
- IS MINIMISING NON- ESSENTIAL COSTS
- WORKING TO BRING POTENTIAL TRANSACTION TO SHAREHOLDERS AND HAVE COMPANY'S SHARES RECOMMENCE TRADING
- DETERMINED THAT A FULL-TIME CEO ROLE WILL NOT BE REQUIRED GOING FORWARD
- SEEKING A TRANSACTION THAT COULD RESULT IN A MATERIAL CHANGE IN COMPANY'S ACTIVITIES
News: EX1 Exopharm Says Ian Dixon's Employment As CEO Expected To End In Early 2024
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.60M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.8¢ | $20.41K | 1.131M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1208900 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 516336 | 3 |
View Market Depth
| Last trade - 11.24am 17/09/2024 (20 minute delay) ? |
| TYP (ASX) Chart |